These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
8. Autoimmune antiphospholipid antibodies: what is their true target? Pengo V; Biasiolo A; Fior MG Haematologica; 1995; 80(2 Suppl):127-30. PubMed ID: 7628765 [No Abstract] [Full Text] [Related]
9. The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin. Bevers EM; Zwaal RF; Willems GM Clin Immunol; 2004 Aug; 112(2):150-60. PubMed ID: 15240158 [TBL] [Abstract][Full Text] [Related]
10. [Antiphospholipid-protein antibodies. Effects on the endothelium-platelet interaction]. Forastiero RR; Martinuzzo ME; Carreras LO Sangre (Barc); 1999 Jun; 44(3):223-30. PubMed ID: 10481585 [No Abstract] [Full Text] [Related]
11. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins. Bertolaccini ML; Hughes GR; Khamashta MA Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Roubey RA Blood; 1994 Nov; 84(9):2854-67. PubMed ID: 7949161 [No Abstract] [Full Text] [Related]
13. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies. Viveros ME; Cabiedes J; Reyes E; Cabral AR Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641 [TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid syndrome]. Yuste JR; Beloqui O; De la Peña A; Prieto J Rev Med Univ Navarra; 1998; 42(4):194-207. PubMed ID: 10420931 [TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion. España F; Villa P; Mira Y; Grancha S; Royo M; Estellés A; Vayá A; Aznar J Haematologica; 1999 Jan; 84(1):80-4. PubMed ID: 10091395 [TBL] [Abstract][Full Text] [Related]
18. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999 [TBL] [Abstract][Full Text] [Related]
19. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
20. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]